PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $401,000 | – | 185,853 | +1858430.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 10 | -100.0% | 0.00% | -100.0% |
Q1 2019 | $768,000 | -53.6% | 206,502 | -65.8% | 0.00% | -66.7% |
Q4 2017 | $1,654,000 | +127.5% | 603,800 | +181.5% | 0.00% | +200.0% |
Q3 2017 | $727,000 | -80.6% | 214,500 | -85.8% | 0.00% | -88.9% |
Q2 2017 | $3,739,000 | -22.8% | 1,513,638 | -29.0% | 0.01% | -30.8% |
Q1 2017 | $4,841,000 | +7.1% | 2,132,600 | 0.0% | 0.01% | -18.8% |
Q4 2016 | $4,521,000 | -36.7% | 2,132,600 | 0.0% | 0.02% | -38.5% |
Q3 2016 | $7,144,000 | +6.7% | 2,132,600 | 0.0% | 0.03% | -3.7% |
Q2 2016 | $6,696,000 | -5.7% | 2,132,600 | 0.0% | 0.03% | -6.9% |
Q1 2016 | $7,102,000 | +15.2% | 2,132,600 | +22.4% | 0.03% | 0.0% |
Q4 2015 | $6,167,000 | +183.8% | 1,742,100 | +303.2% | 0.03% | +222.2% |
Q3 2015 | $2,173,000 | – | 432,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
Leap Investments LP | 69,496 | $150,000 | 0.08% |
Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |